CIK: 1846905 - Address: C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA 02139
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/2/23 16:42
10/31/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBhanji MunaMADS-623.9000-212D
8/2/23 17:19
7/31/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBhanji MunaMADS-1142.3300-212D
7/10/23 17:21
7/6/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBhanji MunaMADS-7339.300-2-1313D
7/7/23 16:17
7/7/23
CYTKCytokinetics IncHealthDrugPharmaceutical PreparationsBhanji MunaCADS-6834.120-2-1214D
6/21/23 16:55
6/16/23
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesBhanji MunaCADS-15626.440-6-1729D
6/1/23 17:06
5/30/23
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesBhanji MunaCADS-4025.910-2-625D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact